New C1-INH ELISA – Fast and Reliable Detection

news March 29 2022

C1 inhibitor (C1-INH) is an important regulator of our immune system, that has originally been discovered as a member of the complement system. It plays however a broader role independent from the complement system, such as in regulation of fibrinolytic system, as well as contact and coagulation system. C1-INH is important in suppression of complement, inflammation and vascular permeability.

The new C1-INH ELISA from Hycult detects fast and reliable the presence C1-INH levels.

View the product here!

The Key Advantages:

  • Short assay time 1 hour and 15 minutes
  • Developed by complement specialist
  • Reliable and robust measurement of C1-INH

Why testing C1-INH?

C1-INH administration is an approved common treatment for hereditary angioedema (HAE) and in clinical trials:

  • Covid-19 infections
  • Prevention of rejection in kidney transplantation
  • Traumatic brain injury and acute ischemic stroke
  • Endotoxemia, sepsis, inflammation and multiple organ failure
  • Application in end stage renal disease and chronic kidney disease

 

Subscribe to our newsletter

Get the latest news within your area of research to your inbox.
Subscribe →